Ductal Carcinoma in Situ of the Breast - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Ductal Carcinoma in Situ of the Breast > What Your Doctor is Reading About Ductal Carcinoma in Situ of the Breast > General Interest Articles

General Interest Articles

1. Predicting a local recurrence after breast-conserving therapy by gene expression profiling.

Author: Nuyten DS; Kreike B; Hart AA; Chi JT; Sneddon JB; Wessels LF; Peterse HJ; Bartelink H; Brown PO; Chang HY; van de Vijver MJ;
Institution: Department of Radiation Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Journal: Breast Cancer Res. 2006;8(5):R62.
Abstract URL: Click here to view abstract

2. Results of 23,810 Cases of Ductal Carcinoma-in-situ.

Author: Sumner WE 3rd; Koniaris LG; Snell SE; Spector S; Powell J; Avisar E; Moffat F; Livingstone AS; Franceschi D;
Institution: Division of Surgical Oncology, Department of Surgery, Sylvester Comprehensive Cancer Center, Room 3550, University of Miami, Miami, Florida, 33136, dfrances@med.miami.edu.
Journal: Ann Surg Oncol. 2007 May;14(5):1638-43. Epub 2007 Jan 24.
Abstract URL: Click here to view abstract

3. BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancer.

Author: Tan EY; Campo L; Han C; Turley H; Pezzella F; Gatter KC; Harris AL; Fox SB;
Institution: Nuffield Department of Clinical Laboratory Sciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
Journal: Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):467-74.
Abstract URL: Click here to view abstract

4. Mechanisms of progression of ductal carcinoma in situ of the breast to invasive cancer A hypothesis.

Author: Cocker R; Oktay MH; Sunkara JL; Koss LG;
Institution: Department of Pathology, Montefiore Medical Center/Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, United States.
Journal: Med Hypotheses. 2007;69(1):57-63. Epub 2007 Jan 25.
Abstract URL: Click here to view abstract

5. p53 Overexpression is a Predictor of Local Recurrence After Treatment for Both in situ and Invasive Ductal Carcinoma of the Breast.

Author: de Roos MA; de Bock GH; de Vries J; van der Vegt B; Wesseling J;
Institution: Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Journal: J Surg Res. 2007 Jun 1;140(1):109-14. Epub 2007 Feb 7.
Abstract URL: Click here to view abstract

6. Patterns and correlates of patient referral to surgeons for treatment of breast cancer.

Author: Katz SJ; Hofer TP; Hawley S; Lantz PM; Janz NK; Schwartz K; Liu L; Deapen D; Morrow M;
Institution: Division of General Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109-0429, USA. skatz@umich.edu
Journal: J Clin Oncol. 2007 Jan 20;25(3):271-6.
Abstract URL: Click here to view abstract

7. Magnetic resonance-guided biopsy of suspicious breast lesions with a handheld vacuum biopsy device.

Author: Gebauer B; Bostanjoglo M; Moesta KT; Schneider W; Schlag PM; Felix R;
Institution: Department of Radiology, Charite, Universitatsmedizin Berlin, Campus Buch, ELIOS-Klinikum Berlin, Berlin, Germany. bernhard.gebauer@charite.de
Journal: Acta Radiol. 2006 Nov;47(9):907-13.
Abstract URL: Click here to view abstract

8. The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions.

Author: Terry G; Ho L; Londesborough P; Duggan C; Hanby A; Cuzick J;
Institution: Department of Epidemiology, Mathematics and Statistics, Cancer Research UK, Queen Mary University of London, Wolfson Institute, Charterhouse Square, London ECIM 6BQ, UK.
Journal: Br J Cancer. 2007 Jan 15;96(1):110-7. Epub 2006 Dec 12.
Abstract URL: Click here to view abstract

9. Ductal carcinoma in situ in BRCA mutation carriers.

Author: Hwang ES; McLennan JL; Moore DH; Crawford BB; Esserman LJ; Ziegler JL;
Institution: University of California, San Francisco Cancer Risk Program and the Carol Franc Buck Breast Care Center, San Francisco CA, USA. shelley.hwang@ucsfmedctr.org
Journal: J Clin Oncol. 2007 Feb 20;25(6):642-7. Epub 2007 Jan 8.
Abstract URL: Click here to view abstract

10. Therapeutic options for Paget's disease: A single institution long-term follow-up study.

Author: Joseph KA; Ditkoff BA; Estabrook A; El-Tamer MB; Banarjee S; Schnabel FR;
Institution
Journal: Breast J. 2007 Jan-Feb;13(1):110-1.

11. Inhibition of breast tumor growth and angiogenesis by a medicinal herb: Ocimum gratissimum.

Author: Nangia-Makker P; Tait L; Shekhar MP; Palomino E; Hogan V; Piechocki MP; Funasaka T; Raz A;
Institution: Tumor Progression and Metastasis, Karmanos Cancer Institute, Wayne State University, School of Medicine, Detroit, MI.
Journal: Int J Cancer. 2007 Apr 16;.
Abstract URL: Click here to view abstract

12. Adjunctive diagnostic value of ultrasonography evaluation in patients with suspected ductal breast disease.

Author: Ballesio L; Maggi C; Savelli S; Angeletti M; Rabuffi P; Manganaro L; Porfiri LM;
Institution: Dipartimento di Scienze Radiologiche, Policlinico Umberto I, Viale del Policlinico 155, I-00161, Roma, Italy, maggicla@inwind.it.
Journal: Radiol Med (Torino). 2007 Apr;112(3):354-365. Epub 2007 Apr 20.
Abstract URL: Click here to view abstract

13. Predicting relapse in ductal carcinoma in situ patients: an analysis of biologic markers with long-term follow-up.

Author: Hieken TJ; Cheregi J; Farolan M; Kim J; Velasco JM; Hieken TJ; Cheregi J; Farolan M; Kim J; Velasco JM;
Institution: Department of Surgery, Rush North Shore Medical Center, 9669 North Kenton Avenue, Suite 204, Skokie, IL 60076, USA. thieken@rush.edu
Journal: Am J Surg. 2007 Oct;194(4):504-6.
Abstract URL: Click here to view abstract

14. Gradient index ductoscopy and intraductal biopsy of intraductal breast lesions.

Author: Hunerbein M; Dubowy A; Raubach M; Gebauer B; Topalidis T; Schlag P;
Institution: Department of Surgery and Surgical Oncology, Charite Campus Buch, Universitatsmedizin Berlin and Helios Hospital, 13122 Berlin, Germany. michael.huenerbein@charite.de
Journal: Am J Surg. 2007 Oct;194(4):511-4.
Abstract URL: Click here to view abstract

15. Disparities in time to definitive surgical treatment between black and white women diagnosed with ductal carcinoma in situ.

Author: Pocock B; Nash S; Klein L; El-Tamer M; Schnabel FR; Joseph KA; Pocock B; Nash S; Klein L; El-Tamer M; Schnabel FR; Joseph KA;
Institution: Comprehensive Breast Center, Department of Surgery, Columbia University Medical Center/New York Presbyterian Hospital, New York, NY 10032, USA. bjp2117@columbia.edu
Journal: Am J Surg. 2007 Oct;194(4):521-3.
Abstract URL: Click here to view abstract

16. Multidisciplinary management of ductal carcinoma in situ: a 10-year experience.

Author: West JG; Qureshi A; Liao SY; Sutherland ML; Chen JW; Chacon M; Fanning C; West JG; Qureshi A; Liao SY; Sutherland ML; Chen JW; Chacon M; Fanning C;
Institution: Department of Surgery, Breast Care Center at the Cordelia Knott Center for Wellness, 230 S Main St, Orange, CA 92868, USA. jwest@breastcare.com
Journal: Am J Surg. 2007 Oct;194(4):532-4.
Abstract URL: Click here to view abstract

17. In situ carcinoma - can we predict which patient will come back with a recurrence?

Author: Simpson PT; Da Silva LM; Lakhani SR;
Institution: Molecular and Cellular Pathology, School of Medicine, University of Queensland, Herston QLD 4006, Australia.
Journal: Cancer Cell. 2007 Nov;12(5):409-11.
Abstract URL: Click here to view abstract

18. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ.

Author: Solin LJ; Orel SG; Hwang WT; Harris EE; Schnall MD;
Institution: Department of Radiation Oncology, Hospital of the University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104, USA. solin@xrt.upenn.edu
Journal: J Clin Oncol. 2008 Jan 20;26(3):386-91.
Abstract URL: Click here to view abstract

19. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.

Author: Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ;
Institution: Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Journal: Br J Surg. 2007 Apr 17;.
Abstract URL: Click here to view abstract

20. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.

Author: Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS;
Institution: Maine Medical Center, Portland, Maine 04102, USA.
Journal: Breast J. 2007 May-Jun;13(3):251-7.
Abstract URL: Click here to view abstract

21. Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge.

Author: Liu GY; Lu JS; Shen KW; Wu J; Chen CM; Hu Z; Shen ZZ; Zhang TQ; Shao ZM;
Institution: Department of Breast Surgery, Cancer Hospital/Cancer Institute, Fudan University, 399 Ling-Ling Road, Shanghai 200032, People's Republic of China.
Journal: Breast Cancer Res Treat. 2008 Mar;108(2):271-7. Epub 2007 May 2.
Abstract URL: Click here to view abstract

22. Diagnostic ultrasonography and mammography for invasive and noninvasive breast cancer in women aged 30 to 39 years.

Author: Osako T; Takahashi K; Iwase T; Iijima K; Miyagi Y; Nishimura S; Tada K; Makita M; Akiyama F; Sakamoto G; Kasumi F;
Institution: Department of Breast Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research.
Journal: Breast Cancer. 2007;14(2):229-33.
Abstract URL: Click here to view abstract

23. Practice guideline for the management of ductal carcinoma in-situ of the breast (DCIS).

Author
Institution: Dana Farber/Brigham and Women's Hospital, Boston, MA, USA.
Journal: J Am Coll Surg. 2007 Jul;205(1):145-161.

24. Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients.

Author: Moran CJ; Kell MR; Flanagan FL; Kennedy M; Gorey TF; Kerin MJ;
Institution: Department of Surgery, National Breast Screening Program, Eccles Unit, University College Dublin, 36 Eccles St, Dublin 7, Ireland.
Journal: Am J Surg. 2007 Aug;194(2):172-5.
Abstract URL: Click here to view abstract

25. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival.

Author: Joslyn SA; Joslyn SA;
Institution: University of Northern Iowa, Cedar Falls, Iowa 50614-0135, USA. sue.joslyn@uni.edu
Journal: Breast J. 2006 Jan-Feb;12(1):20-7.
Abstract URL: Click here to view abstract

26. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.

Author: Li CI; Malone KE; Saltzman BS; Daling JR; Li CI; Malone KE; Saltzman BS; Daling JR;
Institution: Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Epidemiology Program, Seattle, Washington, USA. cili@fhcrc.org
Journal: Cancer. 2006 May 15;106(10):2104-12.
Abstract URL: Click here to view abstract

27. Comparison of MRI features of different grades of DCIS and invasive carcinoma of the breast.

Author: Van Goethem M; Schelfout K; Kersschot E; Colpaert C; Weyler J; Verslegers I; Biltjes I; De Schepper A; Parizel PM; Van Goethem M; Schelfout K; Kersschot E; Colpaert C; Weyler J; Verslegers I; Biltjes I; De Schepper A; Parizel PM;
Institution: Dpt of Radiology, University Hospital Antwerp, Belgium. johan.vangoethem@ua.ac.be
Journal: JBR-BTR. 2005 Sep-Oct;88(5):225-32.
Abstract URL: Click here to view abstract

28. Invasive breast cancer following ductal and lobular carcinoma in situ of the breast.

Author: Levi F; Randimbison L; Te VC; La Vecchia C; Levi F; Randimbison L; Te VC; La Vecchia C;
Institution: Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchatel, Institut universitaire de medecine sociale et preventive, Lausanne, Switzerland. Fabio.Levi@hospvd.ch
Journal: Int J Cancer. 2005 Sep 20;116(5):820-3.
Abstract URL: Click here to view abstract

29. Changing patterns in diagnosis and treatment of ductal carcinoma in situ of the breast.

Author: Meijnen P; Peterse JL; Oldenburg HS; Woerdeman LA; Rutgers EJ; Meijnen P; Peterse JL; Oldenburg HS; Woerdeman LA; Rutgers EJ;
Institution: Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. p.meijnen@nki.nl
Journal: Eur J Surg Oncol. 2005 Oct;31(8):833-9.
Abstract URL: Click here to view abstract

30. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis.

Author: Warren JL; Weaver DL; Bocklage T; Key CR; Platz CE; Cronin KA; Ballard-Barbash R; Willey SC; Harlan LC; Warren JL; Weaver DL; Bocklage T; Key CR; Platz CE; Cronin KA; Ballard-Barbash R; Willey SC; Harlan LC;
Institution: Health Services and Economics Branch/Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892-7344, USA. joan_warren@nih.gov
Journal: Cancer. 2005 Nov 1;104(9):1840-8.
Abstract URL: Click here to view abstract

31. Compliance with guidelines is related to better local recurrence-free survival in ductal carcinoma in situ.

Author: de Roos MA; de Bock GH; Baas PC; de Munck L; Wiggers T; de Vries J; de Roos MA; de Bock GH; Baas PC; de Munck L; Wiggers T; de Vries J;
Institution: Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, The Netherlands. mderoos@tiscali.nl
Journal: Br J Cancer. 2005 Nov 14;93(10):1122-7.
Abstract URL: Click here to view abstract

32. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging.

Author: Menell JH; Morris EA; Dershaw DD; Abramson AF; Brogi E; Liberman L; Menell JH; Morris EA; Dershaw DD; Abramson AF; Brogi E; Liberman L;
Institution: Breast Imaging Section, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. jmenell@mkmg.com
Journal: Breast J. 2005 Nov-Dec;11(6):382-90.
Abstract URL: Click here to view abstract

33. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.

Author: Maffuz A; Barroso-Bravo S; Najera I; Zarco G; Alvarado-Cabrero I; Rodriguez-Cuevas SA; Maffuz A; Barroso-Bravo S; Najera I; Zarco G; Alvarado-Cabrero I; Rodriguez-Cuevas SA;
Institution: Breast Tumor Department, Hospital de Oncologia, Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico. tonomaffuz@yahoo.com
Journal: J Exp Clin Cancer Res. 2006 Jun;25(2):223-7.
Abstract URL: Click here to view abstract

34. Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast.

Author: Lee LA; Silverstein MJ; Chung CT; Macdonald H; Sanghavi P; Epstein M; Holmes DR; Silberman H; Ye W; Lagios MD; Lee LA; Silverstein MJ; Chung CT; Macdonald H; Sanghavi P; Epstein M; Holmes DR; Silberman H; Ye W; Lagios MD;
Institution: Keck School of Medicine, University of Southern California, Los Angeles, CA 90033-0800, USA. lalee1061@gmail.com
Journal: Am J Surg. 2006 Oct;192(4):416-9.
Abstract URL: Click here to view abstract

35. Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast.

Author: Macdonald HR; Silverstein MJ; Lee LA; Ye W; Sanghavi P; Holmes DR; Silberman H; Lagios M; Macdonald HR; Silverstein MJ; Lee LA; Ye W; Sanghavi P; Holmes DR; Silberman H; Lagios M;
Institution: USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, 1441 Eastlake Ave., Room 7415, Los Angeles, CA 90033-0800, USA. macdonald_hr@yahoo.com
Journal: Am J Surg. 2006 Oct;192(4):420-2.
Abstract URL: Click here to view abstract

36. What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?

Author: Mabry H; Giuliano AE; Silverstein MJ; Mabry H; Giuliano AE; Silverstein MJ;
Institution: Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute, 2200 Santa Monica Blvd., Santa Monica, CA 90404, USA. helenmabrymd@yahoo.com
Journal: Am J Surg. 2006 Oct;192(4):455-7.
Abstract URL: Click here to view abstract

37. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.

Author: Dillon MF; McDermott EW; Quinn CM; O'Doherty A; O'Higgins N; Hill AD; Dillon MF; McDermott EW; Quinn CM; O'Doherty A; O'Higgins N; Hill AD;
Institution: Department of Surgery, St Vincent's University Hospital, Dublin, Ireland.
Journal: J Surg Oncol. 2006 Jun 1;93(7):559-63.
Abstract URL: Click here to view abstract

38. Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast.

Author: Smith GL; Smith BD; Haffty BG; Smith GL; Smith BD; Haffty BG;
Institution: Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA.
Journal: Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1397-403. Epub 2006 Jun 5.
Abstract URL: Click here to view abstract

39. Prospective changes in quality of life after ductal carcinoma-in-situ: results from the Nurses' Health Study.

Author: Nekhlyudov L; Kroenke CH; Jung I; Holmes MD; Colditz GA; Nekhlyudov L; Kroenke CH; Jung I; Holmes MD; Colditz GA;
Institution: Department of Ambulatory Care and Prevention, Harvard Medical School/Harvard Pilgrim Health Care, Boston, MA 02215, USA. larissa_nekhlyudov@harvardpilgrim.org
Journal: J Clin Oncol. 2006 Jun 20;24(18):2822-7.
Abstract URL: Click here to view abstract

40. Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice.

Author: Dillon MF; Quinn CM; McDermott EW; O'Doherty A; O'Higgins N; Hill AD;
Institution: Department of Surgery, St Vincent's University Hospital, Dublin.
Journal: J Clin Pathol. 2006 Jul;59(7):740-3.
Abstract URL: Click here to view abstract

41. Clinical presentation and surgical quality in treatment of ductal carcinoma in situ of the breast.

Author: Schouten van der Velden AP; Peeters PH; Koot VC; Hennipman A;
Institution: Julius Centre for Health Sciences and Primary Care, University Medical Centre, Utrecht, the Netherlands.
Journal: Acta Oncol. 2006;45(5):544-9.
Abstract URL: Click here to view abstract

42. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.

Author: Sanders, Melinda E; Schuyler, Peggy A; Dupont, William D; Page, David L;
Institution: Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-5310, USA. melinda.sanders@vanderbilt.edu
Journal: Cancer 2005 Jun 15;103(12):2481-4.
Abstract URL: Click here to view abstract

43. Patterns and correlates of local therapy for women with ductal carcinoma-in-situ.

Author: Katz, Steven J; Lantz, Paula M; Janz, Nancy K; Fagerlin, Angela; Schwartz, Kendra; Liu, Lihua; Deapen, Dennis; Salem, Barbara; Lakhani, Indu; Morrow, Monica;
Institution: Department of Medicine and Health Management and Policy, University of Michigan, 300 N Ingalls, Ste 7E12, Box 0429, Ann Arbor, MI 48109-0429, USA. skatz@umich.edu
Journal: J Clin Oncol 2005 May 1;23(13):3001-7.
Abstract URL: Click here to view abstract

44. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.

Author: Li, Christopher I; Daling, Janet R; Malone, Kathleen E;
Institution: Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M4-C308, P.O. Box 19024, Seattle, WA 98109-1024, USA. cili@fhcrc.org
Journal: Cancer Epidemiol Biomarkers Prev 2005 Apr;14(4):1008-11.
Abstract URL: Click here to view abstract

45. Relationship between hormone receptor status and tumour size, grade and comedo necrosis in ductal carcinoma in situ.

Author: Barnes, N L P; Boland, G P; Davenport, A; Knox, W F; Bundred, N J;
Institution: Department of Academic Surgery, South Manchester University Hospital, Southmoor Road, Manchester M23 9LT, UK.
Journal: Br J Surg 2005 Apr;92(4):429-34.
Abstract URL: Click here to view abstract

46. Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ.

Author: Claus, Elizabeth B; Petruzella, Stacey; Matloff, Ellen; Carter, Darryl;
Institution: Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn 06520-8034, USA. elizabeth.claus@yale.edu
Journal: JAMA 2005 Feb 23;293(8):964-9.
Abstract URL: Click here to view abstract